| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |